← 返回前沿论文

产品内在的 NF-κB 驱动转录程序提示多发性骨髓瘤中 CAR-T 应答的持久性

英文原题:Product-intrinsic NF-κB-driven transcriptional programs connote durability of CAR-T response in multiple myeloma.

PubMed 2026/09/10(内容时间) Blood Q1 · IF 23.9(JCR 2025)

研究概要

idecabtagene vicleucel(ide-cel)可在复发/难治性多发性骨髓瘤中诱导深度缓解,但超过一半的患者在 1 年内复发。

中文摘要

Idecabtagene vicleucel (ide-cel) 可在复发/难治性多发性骨髓瘤中引起深度反应,但超过一半的患者在 1 年内复发。CAR-T 细胞 产品区分持久反应和非持久反应的内在特征尚不清楚,特别是在单细胞分辨率下,而确定持久反应的驱动因素对于指导患者咨询和为优化 CAR-T 制造和功效的策略提供信息至关重要。为了满足这一需求,我们使用单细胞 RNA 测序对 40 种 ide-cel 输注产品(184 398 个细胞)进行了分析。这些分析表明,CD4 CAR-T 细胞中导致持久反应的转录程序的特征是 NF-B 信号传导、促生存回路、强直/趋化因子信号传导和 CAR 转基因表达升高。无论基线临床特征如何,这些特征都与延长的无进展生存期和总生存期相关。此外,对配对单采和肿瘤微环境样本的分析表明,NF-B活性升高是T细胞健康的内在标志,其特征是中央记忆表型和检查点受体表达的缺乏,并且这些特征在CAR-T制造之前在骨髓来源和外周血T细胞中表现出来。最后,验证功能相关性,NF-B 的药理学抑制消除了 CAR-T 细胞毒性和体外细胞因子产生。我们的结果支持,ide-cel 产品中的 NF-B 标志着影响 CAR-T 功能的信号轴,并且 NF-B 活性代表了 CAR-T 制造之前存在的 T 细胞适应性的全局标志。

展开英文摘要原文

Idecabtagene vicleucel (ide-cel) induces deep responses in relapsed/refractory multiple myeloma, yet more than half of patients relapse within 1 year. The intrinsic features of chimeric antigen receptor T-cell (CAR-T) products that distinguish durable from nondurable responders are poorly defined, particularly at single-cell resolution, and defining drivers of durable response is critical to guide patient counseling and to inform strategies for optimizing CAR-T manufacturing and efficacy. To address this need, 40 ide-cel infusion products (184 398 cells) were profiled using single-cell RNA sequencing. These analyses revealed that a transcriptional program in CD4 CAR-T cells that led to durable responses is characterized by NF- B signaling, prosurvival circuits, tonic/chemokine signaling, and elevated CAR transgene expression. These features were associated with prolonged progression-free and overall survival irrespective of baseline clinical characteristics. Further, analyses of paired apheresis and tumor microenvironment samples showed that elevated NF- B activity is an intrinsic hallmark of T-cell fitness that is characterized by a central memory phenotype and the lack of checkpoint receptor expression, and that these features were manifest in marrow-derived and peripheral blood T cells before CAR-T manufacturing. Finally, validating functional relevance, the pharmacologic inhibition of NF- B abrogated CAR-T cytotoxicity and cytokine production in vitro. Our results support that NF- B in the ide-cel product marks a signaling axis affecting CAR-T function and that NF- B activity represents a global marker of T-cell fitness present before CAR-T manufacture.

论文信息

作者
Noble JD、Peixoto BC、Menges MA、Abraham-Miranda J、Savid-Frontera C、Sawyer W、Sorathia VD、Cuadrado Delgado LA
第一作者单位
Department of Clinical Science, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.United States
通讯作者单位
Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.United States
期刊
Blood2026 Sep 10
原文标识
PubMed 42275255 · DOI 10.1182/blood.2025031843